Workflow
QuidelOrtho (QDEL)
icon
Search documents
QuidelOrtho (QDEL) - 2022 Q3 - Earnings Call Transcript
2022-11-03 02:10
QuidelOrtho Corporation (NASDAQ:QDEL) Q3 2022 Earnings Conference Call November 2, 2022 5:00 PM ET Company Participants Bryan Brokmeier - Vice President, Investor Relations Douglas Bryant - Chairman and CEO Joseph Busky - CFO Conference Call Participants Andrew Cooper - Raymond James Patrick Donnelly - Citi Andrew Brackmann - William Blair Alexander Nowak - Craig Hallum Casey Woodring - JP Morgan Operator Welcome to the QuidelOrtho Third Quarter 2022 Financial Results Conference Call and Webcast. At this ti ...
QuidelOrtho (QDEL) - 2022 Q3 - Earnings Call Presentation
2022-11-02 22:06
| --- | --- | |-----------------------------------|-------| | | | | | | | Forging the Future of Diagnostics | | | Financial Results 3Q 2022 | | Forward-Looking Statements Forward-Looking Statements: This presentation of QuidelOrtho Corporation ("QuidelOrtho" or the "Company") contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements and other forward-looking statements in this presentation by words such as "may," "will ...
QuidelOrtho (QDEL) - 2023 Q2 - Quarterly Report
2022-08-05 21:27
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________ FORM 10-Q ____________________________________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 3, 2022 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commi ...
QuidelOrtho (QDEL) - 2022 Q2 - Earnings Call Transcript
2022-08-05 01:37
QuidelOrtho Corporation (NASDAQ:QDEL) Q2 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Bryan Brokmeier - Vice President, Investor Relations Douglas Bryant - Chairman and CEO Joseph Busky - CFO Conference Call Participants Jack Meehan - Nephron Research Andrew Cooper - Raymond James Casey Woodring - JP Morgan Alex Nowak - Craig Hallum Operator Welcome to the QuidelOrthoÂ's Second Quarter 2022 Financial Results Conference Call and Webcast. At this time, all participants lines are in ...
QuidelOrtho (QDEL) - 2022 Q2 - Earnings Call Presentation
2022-08-04 21:09
| --- | |-------| | | | | | | | | Forward-Looking Statements Forward-Looking Statements: This presentation of QuidelOrtho Corporation ("QuidelOrtho" or the "Company") contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements and other forward-looking statements in this presentation by words such as "may," "will," "would," "expect," "anticipate," "believe," "estimate," "plan," "intend," "continue," or similar words, exp ...
QuidelOrtho (QDEL) - 2022 Q1 - Earnings Call Transcript
2022-05-07 22:23
Ortho Clinical Diagnostics Holdings PLC (OCDX) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Bryan Brokmeier - Vice President, Investor Relations Chris Smith - Chairman and Chief Executive Officer Joseph Busky - Chief Financial Officer Operator Welcome to the Ortho Clinical Diagnostics First Quarter 2022 Earnings Conference Call and Webcast. At this time, all participants lines are in a listen-only mode. Please note this conference is being recorded. An audio replay of the con ...
QuidelOrtho (QDEL) - 2022 Q1 - Earnings Call Presentation
2022-05-05 07:24
| --- | --- | --- | --- | |--------------------------------------|----------------------|-------|-------| | | | | | | | | | | | | Earnings Results | | | | INVESTOR PRESENTATION (Nasdaq: OCDX) | 1Q 2022 May 04, 2022 | | | © Ortho Clinical Diagnostics 2022 Forward-Looking Statements This presentation and the oral remarks may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forwa ...
Quidel Corporation (QDEL) Presents at ACC 2022 - Slideshow
2022-04-05 17:18
Quidel Corporation Raymond James March 2022 Copyright © 2022 Quidel Corporation. All rights reserved. Forward-Looking Statements and Additional Information Where You Can Find Additional Information In connection with the proposed business combination transaction among Quidel Corporation (the "Company"), Ortho Clinical Diagnostics Holdings plc ("Ortho") and Coronado Topco, Inc. ("Topco"), Topco has filed a registration statement on Form S-4 with the Securities and Exchange Commission (the "Commission") that ...
QuidelOrtho (QDEL) - 2021 Q4 - Earnings Call Transcript
2022-02-18 01:36
Quidel Corporation (NASDAQ:QDEL) Q4 2021 Earnings Conference Call February 17, 2022 5:00 PM ET Company Participants Ruben Argueta – Director of Investor Relations Doug Bryant – President and Chief Executive Officer Randy Steward – Chief Financial Officer Joe Busky – Chief Financial Officer, Ortho Clinical Diagnostics Holdings Chris Smith – Chairman and Chief Executive Officer, Ortho Clinical Diagnostics Holdings Rob Bujarski – Chief Operating Officer Conference Call Participants Tycho Peterson – JPMorgan Br ...
QuidelOrtho (QDEL) - 2021 Q3 - Earnings Call Transcript
2021-11-07 20:45
Ortho Clinical Diagnostics Holdings plc (OCDX) Q3 2021 Earnings Conference Call November 3, 2021 5:00 PM ET Company Participants Bryan Brokmeier - Vice President of Investor Relations Chris Smith - Chairman & Chief Executive Officer Joe Busky - Chief Financial Officer Mike Iskra - Executive Vice President of Commercial Excellence & Strategy Conference Call Participants Tycho Peterson - JP Morgan Vijay Kumar - ISI Derik De Bruin - Bank of America Matt Sykes - Goldman Sachs Patrick Donnelly - Citi Tejas Savan ...